An indication marks the headquarters of Moderna Therapeutics, which is growing a vaccine towards the coronavirus illness (COVID-19), in Cambridge,
An indication marks the headquarters of Moderna Therapeutics, which is growing a vaccine towards the coronavirus illness (COVID-19), in Cambridge, Massachusetts.
Brian Snyder | Reuters
Moderna is prepping for the worldwide launch of its potential coronavirus vaccine, already taking in $1.1 billion in deposits from governments awaiting the possibly lifesaving drug, the biotech agency stated Thursday in its third-quarter earnings report.
“We’re actively getting ready for the launch of mRNA-1273 and we’ve got signed quite a few provide agreements with governments world wide,” Moderna CEO Stephane Bancel stated in a press launch. “Moderna is dedicated to the very best knowledge high quality requirements and rigorous scientific analysis as we proceed to work with regulators to advance mRNA-1273.”
This can be a growing story. Please verify again for updates.